Replies to post #416944 on Anavex Life Sciences Corp (AVXL)

[Anshu2]

1. Why did CM not talk about OR and thresholds BEFORE December 22, in any of his numerous conference presentations? Is non-transparency the fundamental aspect of company's policies and business model?

2. Why did CM not address many of the obvious mistakes (as per the whole world, around him) in the December, 22 data release? Because he cannot?

3. Why did he never disclose delta-RSBQ for the Avatar study -- even if he, mysteriously, decide to switch to RSBQ-AUC endpoint?

4. Why does it take the company months/years to disclose full results?

These are the Qs that should have been asked.